NCT07930247
Blood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential Hypertension
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Proportion of patients achieving blood pressure control rates at Week 24 after treatment with Ex-one tablets or Ex-one Plus tablets
Timeframe: At Week 24 after enrollment
Sites
1 site in 1 country
- HK inno.NSeoul, South Korea